A Tumor-on-a-chip Platform For Screening Precision Medicine-driven Therapies

被引：0
|
作者：
Forsythe, S. [1 ]
Mehta, N. [1 ]
Alistar, A. [2 ,3 ]
Hall, A. [1 ,3 ,4 ]
Skardal, A. [1 ,3 ,4 ]
机构：
[1] Wake Forest Baptist Med Ctr, Inst Regenerat Med, Winston Salem, NC USA
[2] Wake Forest Baptist Med Ctr, Hematol & Oncol, Winston Salem, NC USA
[3] Wake Forest Baptist Med Ctr, Ctr Comprehens Canc, Winston Salem, NC USA
[4] Wake Forest Baptist Med Ctr, Biomed Engn, Winston Salem, NC USA
来源：
TISSUE ENGINEERING PART A | 2016年 / 22卷
关键词：
D O I：
暂无
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
129
引用
收藏
页码：S35 / S36
页数：2
相关论文
共 50 条
  • [41] Precision medicine-based therapies in advanced colorectal cancer: The University of California San Diego Molecular Tumor Board experience
    Louie, Bryan H.
    Kato, Shumei
    Kim, Ki Hwan
    Lim, Hyo Jeong
    Lee, Suzanna
    Okamura, Ryosuke
    Fanta, Paul T.
    Kurzrock, Razelle
    MOLECULAR ONCOLOGY, 2022, 16 (13) : 2575 - 2584
  • [42] Advancing Drug Screening Precision by a Microfluidic Concentration Gradient-on-Chip Platform Fabricated Using a Frugal Hydrogel-Molding Technique
    Dhar, Dhruba
    Chatterjee, Jyotirmoy
    Das, Soumen
    SSRN,
  • [43] MatchMiner: An open-source computational platform for genomically-driven matching of cancer patients to precision medicine clinical trials
    Mazor, Tali
    Keller, Rachel B.
    Kumari, Priti
    Lindsay, James
    Marriott, Eric
    Ovalle, Andrea
    Siegel, Ethan
    Williams, Elizabeth H.
    Yu, Joyce
    Hassett, Michael
    Cerami, Ethan
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)
  • [44] A PRECISION MEDICINE PLATFORM FOR ACUTE MYELOID LEUKEMIA TO HELP UNRAVELING THE MOLECULAR ADDICTIONS OF FLT3-ITD-DRIVEN AML
    Ayuda-Duran, P.
    Zhang, B.
    Piechaczyk, L.
    Popa, M.
    Tadele, D.
    Rowe, A.
    Robertson, J.
    Gedde-Dahl, T.
    Mc Cormack, E.
    Gjertsen, B. T.
    Floisand, Y.
    Enserink, J. M.
    HAEMATOLOGICA, 2017, 102 : 357 - 357
  • [45] MatchMiner: An open-source computational platform for genomically-driven matching of cancer patients to precision medicine clinical trials
    Mazor, Tali
    Keller, Rachel B.
    Kumai, Priti
    Lindsay, James
    Marriott, Eric
    Ovalle, Andrea
    Siegel, Ethan
    Yu, Joyce
    Hassett, Michael
    Cerami, Ethan
    CANCER RESEARCH, 2020, 80 (16)
  • [46] Selectively cross-linked hydrogel-based cocktail drug delivery micro-chip for colon cancer combinatorial drug screening using AI-CSR platform for precision medicine
    Kaladharan, Kiran
    Ouyang, Chih-Hsuan
    Yang, Hsin-Yu
    Tseng, Fan-Gang
    LAB ON A CHIP, 2024, 24 (20) : 4766 - 4777
  • [47] Utility of Molecular Tumor Board Driven by Precision Medicine Service and Cloud-Based Datamart for Therapy and Trial Matching
    Hicks, J. K.
    Saltos, A.
    Aminpour, A.
    Chiappori, A.
    Ozakinci, H.
    Rollison, D. E.
    Reisman, P.
    Creed, J.
    Boyle, T. A.
    Simon, G. R.
    Gray, J. E.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S167 - S167
  • [48] In Vitro Tumor Models on Chip and Integrated Microphysiological Analysis Platform (MAP) for Life Sciences and High-Throughput Drug Screening
    Ngo, Huyen
    Amartumur, Sarnai
    Tran, Van Thi Ai
    Tran, Minh
    Diep, Yen N.
    Cho, Hansang
    Lee, Luke P.
    BIOSENSORS-BASEL, 2023, 13 (02):
  • [49] AI driven single cell analysis of drug action in solid tumor material: An entry point to functional precision medicine.
    Aranha, Valentin
    Tomaz, Diogo
    Perez, Irene Gutierrez
    Rohrer, Florian
    Van Ham, Joost
    Hefler, Lukas
    Hadjari, Laudia
    Lafleur, Judith
    Krall, Nikolaus
    Sehlke, Robert
    Vilagos, Bojan
    Vladimer, Gregory Ian
    CANCER RESEARCH, 2021, 81 (13)
  • [50] Circulating tumor DNA landscape and prognostic impact of acquired resistance to targeted therapies in cancer patients: a national center for precision medicine (PRISM) study
    Bayle, Arnaud
    Belcaid, Laila
    Palmieri, Lola-Jade
    Teysonneau, Diego
    Cousin, Sophie
    Spalato-Ceruso, Mariella
    Aldea, Mihaela
    Vasseur, Damien
    Alame, Melissa
    Blouin, Laura
    Soubeyran, Isabelle
    Nicotra, Claudio
    Ngocamus, Maud
    Hollebecque, Antoine
    Loriot, Yohann
    Besse, Benjamin
    Lacroix, Ludovic
    Rouleau, Etienne
    Barlesi, Fabrice
    Andre, Fabrice
    Italiano, Antoine
    MOLECULAR CANCER, 2023, 22 (01)
12345